Year: 2021
Type: article
Abstract: Aging and cancer are two interrelated processes, with aging being a major risk factor for the development of cancer. Parallel epigenetic alterations have been described for both, although differences, especially within the DNA hypomethylation scenario, have also been recently reported. Although many of these observations arise from the use of mouse models, there is a lack of systematic comparisons of human and mouse epigenetic patterns in the context of disease. However, such comparisons are significant as they allow to establish the extent to which some of the observed similarities or differences arise from pre-existing species-specific epigenetic traits. Here, we have used reduced representation bisulfite sequencing to profile the brain methylomes of young and old, tumoral and nontumoral brain samples from human and mouse. We first characterized the baseline epigenomic patterns of the species and subsequently focused on the DNA methylation alterations associated with cancer and aging. Next, we described the functional genomic and epigenomic context associated with the alterations, and finally, we integrated our data to study interspecies DNA methylation levels at orthologous CpG sites. Globally, we found considerable differences between the characteristics of DNA methylation alterations in cancer and aging in both species. Moreover, we describe robust evidence for the conservation of the specific cancer and aging epigenomic signatures in human and mouse. Our observations point toward the preservation of the functional consequences of these alterations at multiple levels of genomic regulation. Finally, our analyses reveal a role for the genomic context in explaining disease- and species-specific epigenetic traits.
Source: Molecular Biology and Evolution
Institutions: Consejo Superior de Investigaciones Científicas, Universidad de Oviedo, Instituto de Salud Carlos III, Centre for Biomedical Network Research on Rare Diseases, Centro de Investigación Biomédica en Red, Nanomaterials and Nanotechnology Research Center, Instituto de Investigación Sanitaria del Principado de Asturias, Universitat Autònoma de Barcelona, Biomedical Research Networking Center in Bioengineering, Biomaterials and Nanomedicine, Bellvitge University Hospital, Institut d'Investigació Biomédica de Bellvitge, Madrid Institute for Advanced Studies, IMDEA Food, Institució Catalana de Recerca i Estudis Avançats, Spanish National Cancer Research Centre, Institute for Research in Biomedicine, Barcelona Institute of Science and Technology
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: gold
Estimated APC paid: $3,255
OpenAlex ID: W3156231141
